Clinical Trial Update: Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study [NA]

View source ↗

Summary

A pilot study is evaluating fecal microbiota transplantation in adults with type 2 diabetes mellitus and coronary artery disease; the trial is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Zurich | Conditions: Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM) | NA | Status: NOT_YET_RECRUITING